Challenges for the present CKD classification system

Current Opinion in Nephrology and Hypertension

Volumn 19, Issue 3, 2010, Pages 308-314

  Gansevoort, Ron T ^a   De Jong, Paul E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Ageing; Albuminuria; Chronic kidney disease; Classification; EGFR; Elderly

Indexed keywords

CYSTATIN C;

AGING; ALBUMINURIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; ORGANIZATION; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR;

HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 77951468995     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328337bbbe     Document Type: Review

References (65)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
2. Levey AS, Coresh J, Balk et al. NKF practice guidelines for CKD: evaluation, classification and stratification. Arch Intern Med 2003; 139:137-147.
3. Bauer C, Melamed ML, HostetterTH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 2008; 19:844-846.
4. Connolly JO, Woolfson RG. A critique of clinical guidelines for detection of individuals with chronic kidney disease. Nephron Clin Pract 2009; 111:c69-c73.
5. Gansevoort RT, de Jong PE. The case for using albuminuria in staging chronic kidney disease. J Am Soc Nephrol 2009; 20:465-468.
6. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transpl 2008; 23:1117-1123.
7. Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc 2009; 120:419-428.
8. Glassock RJ, Winearls C. The global burden of chronic kidney disease: how valid are the estimates? Nephron Clin Pract 2008; 110:c39-c46.
9. Glassock RJ. Estimated glomerular filtration rate: time for a performance review? Kidney Int 2009; 75:1001-1003.
10. IkizlerTA. CKD classification: time to move beyond KDOQI. J Am Soc Nephrol 2009; 20:929-930.
11. de Jong PE, Gansevoort RT. Focus on microalbuminuria to improve cardiac and renal protection. Nephron Clin Pract 2009; 111:c204-c210.
12. de Jong PE, Gansevoort RT. Fact or fiction of the epidemic of chronic kidney disease: let us not squabble about estimated GFR only, but also focus on albuminuria. Nephrol Dial Transplant 2008; 23:1092-1095.
13. Mann SJ. Pitfalls in diagnosing chronic kidney disease from eGFR. Arch Intern Med 2009; 169:1168-1169.
14. Winearls CG, Glassock RJ. Dissecting and refining the staging of chronic kidney disease. Kidney Int 2009; 75:1009-1014.
15. Winearls CG. Chronic kidney disease: definition and staging: an orthodox view. Clin Med 2009; 9:563-564.
16. Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict GFR from serum creatinine. J Am Soc Nephrol 2000; 11:155A.
17. Stevens LA, Coresh J, Greene T, et al. Assessing kidney function: measured and estimated GFR. N Engl J Med 2006; 354:2473-2483.
18. Poge U, Gerhardt T, Stoffel-Wagner B, et al. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2006; 21:660-664. (Pubitemid 43372911)
19. Botev R, Mallie JP, Couchoud C, et al. Estimating glomerular filtration rate: Cockcroft-Gault and modification of diet in renal disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol 2009; 4:899-906.
20. Bosma RJ, Doorenbos CR, Stegeman CA, et al. Predictive performance of renal function equations in renal transplant recipients: an analysis of patient factors in bias. Am J Transplant 2005; 5:2193-2203.
21. Jones CY, Jones CA, Wilson IB, et al. Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study. Am J Kidney Dis 2008; 51:914-924.
22. Agarwal R, Bills JE, Yigazu PM, et al. Assessment of iothalamate plasma clearance: duration of study affects quality of GFR. Clin J Am Soc Nephrol 2009; 4:77-85.
23. Frennby B, Sterner G, Almen T, et al. Clearance of iohexol, EDTA, and creatinine for determining the glomerular filtration rate in pigs with normal renal function. A comparison of different clearance techniques. Acad Radiol 1996; 3:651-659.
24. Michels WM, Grootendorst DC, Rozemeijer K, et al. Glomerular filtration rate measurements by 125I-iothalamate should be corrected for inaccurate urine collections with 131I-hippuran. Clin Nephrol 2009; 72:337-343.
25. Verhave JC, Fesler P, Ribstein J, et al. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46:233-241.
26. Apperloo JJ, Gerlag PG, Beerenhout CH, Vader HL. Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients. Ned Tijdschr Geneeskd 2007; 151:1016-1023.
27. Levey AS, Stevens LA, Schmid CH, et al., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
28. Chew JS, Saleem M, Florkowski CM, George PM. Cystatin C-a paradigm of evidence based laboratory medicine. Clin Biochem Rev 2008; 29:47-62.
29. Knight EL, Verhave JC, Spiegelman D, etal. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004; 65:1416-1421.
30. Stevens LA, Schmid CH, Greene T, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009; 75:652-660.
31. Manetti L, Pardini E, Genovesi M, et al. Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest 2005; 28:346-349.
32. Madero M, Sarnak MJ, Stevens LA. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens 2006; 15:610-616.
33. Stevens LA, Coresh J, Schmid CH, etal. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 2008; 51:395-406.
34. Astor BC, Levey AS, Stevens LA, et al. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 2009; 20:2214-2222.
35. Stevens LA, Coresh J, Feldman HI, etal. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18:2749-2757.
36. FliserD. Ren sanusin corporesano:the myth of the inexorable decline of renal function with senescence. Nephrol Dial Transplant 2005; 20:482-485.
37. Wetzels JF, Willems HL, den Heijer M. Age-and gender-specific reference values of estimated glomerular filtration rate in a Caucasian population: results of the Nijmegen Biomedical Study. Kidney Int 2008; 73:657-658.
38. Poggio ED, Rule AD. A critical evaluation of CKD: should isolated reduced GFR be considered a 'disease'? Nephrol Dial Transplant 2009; 24:698-700.
39. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007; 18:2758-2765. (Pubitemid 47531203)
40. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 2006; 17:846-853.
41. de Jong PE, van der Velde M, Gansevoort RT, Zoccali C. Screening for chronic kidney disease: where does Europe go? Clin J Am Soc Nephrol 2008; 3:616-623.
42. Halbesma N, Kuiken DS, Brantsma AH, etal. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006; 17:2582-2590.
43. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
44. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371:2173-2182.
45. Johal M, Levin A. Vitamin D and parathyroid hormone in general populations. Understandings in 2009 and applications to chronic kidney disease. Clin J Am Soc Nephrol 2009; 4:1508-1514.
46. Radtke HW, Claussner A, Erbes PM, et al. Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood 1979; 54:877-884.
47. Iseki K, Kinjo K, Iseki C, Takishita S. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan. Am J Kidney Dis 2004; 44:806-814.
48. Ishani A, Grandits GA, Grimm RH, et al., for the MRFIT Research group. Association of single measurements of dipstick proteinuria, estimated GFR, and hematocrit with 25yr incidence of ESRD in the MRFIT study. J Am Soc Nephrol 2006; 17:1444-1452.
49. Konta T, Hao Z, Takasaki S, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol 2007; 11:51-55.
50. Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 2003; 63:1468-1474. (Pubitemid 36350012)
51. Brantsma AH, Bakker SJL, Hillege HL, et al. Cardiovascular and renal outcome in subjects with KDOQI stages I-III chronic kidney disease; the importance of urinary albumin excretion. Nephrol Dial Transpl 2008; 23: 3851-3858.
52. Matsushita K, Selvin E, Bash LD, et al. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 2009; 20: 2617-2624.
53. Rifkin DE, Shlipak MG, Katz R, et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008; 168:221 2-2218.
54. Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol 2009; 20:2625-2630
55. van der Velde M, Halbesma N, de Charro FT, et al. Can screening for albuminuria identify subjects at increased renal risk? J Am Soc Nephrol 2009; 20:852-862.
56. Hallan SI, Ritz E, Lydersen S, etal. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20:1069-1077.
57. Cirillo M, Lanti MP, Menotti A, et al. Definition of kidney dysfunction as a cardiovascular risk factor: use of urinary albumin excretion and estimated glomerular filtration rate. Arch Intern Med 2008; 168:617-624.
58. Hillege HL, Fidler V, Diercks GFH, et al., for the PREVEND study group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106:1777-1782.
59. Tonelli M, Jose P, Curhan G, et al., and CARE trial investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial. BMJ 2006; 332:1426-1431.
60. Foster MC, Hwang S-J, Larson MG, et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate. Arch Intern Med 2007; 167:1386-1392.
61. Astor BC, Hallan SI, Miller ER 3rd, etal. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008; 167:1226-1234.
62. Hallan S, Astor B, Romundstad S, et al. Association of kidney function and albuminuria with cardiovascular mortality in older versus younger individuals. Arch Intern Med 2007; 167:2490-2496.
63. Crowe E, Halpin D, Stevens P, Guideline Development Group. Early identification and management of chronic kidney disease: summary of NICE guidance. BMJ 2008; 337:a1530.
64. de Grauw WJC, Kaasjager HAH, Bilo HJG, et al. National Dutch transmural guideline chronic kidney damage. Huisarts Wteenschap 2009; 52:586-597.
65. Eckardt KU, Berns JS, Rocco MV, Kasiske BL. Definition and classification of CKD: the debate should be about patient prognosis: a position statement from KDOQI and KDIGO. Am J Kidney Dis 2009; 53:915-920.